Literature DB >> 17579365

Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.

Keeley J Brookes1, Benjamin M Neale, Karen Sugden, Nadeem Khan, Philip Asherson, Ursula M D'Souza.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is currently one of the most prevalent childhood behavioral disorders. The disorder is found to be highly heritable, suggesting a large genetic component. Association studies have repeatedly implicated the dopamine transporter (DAT1) gene, and in particular the 10-repeat allele of a variable number tandem repeat (VNTR) polymorphism located in the 3'UTR of the gene. Inconclusive data has been generated from several earlier studies on the functional effects of this polymorphism. Therefore, there is call for further investigation and thus the focus on data described here from TaqMan RT-PCR assays. The expression levels of the DAT1 gene from post-mortem midbrain tissue was measured in relation to the polymorphism present at the 3'UTR VNTR, together with a further VNTR marker located within intron 8 of the gene (Int8 VNTR). The findings suggest that the presence of the 10-repeat allele of the 3'UTR VNTR, the 3-repeat of the intron 8 VNTR and both VNTR markers are correlated with increased levels of the DAT1 transcript in midbrain post-mortem tissue. Further work using linear regression (LR) shows agreement with the correlation analysis, and either nominal significance or a trend in that direction. Given the small sample size, bootstrapping-derived confidence intervals were calculated for the LR. These empirical analyses suggest that the 3'UTR VNTR to show a significant main effect on relative DAT1 expression. Furthermore, a significant effect was found for the combined model (3'UTR and Int8 VNTR markers) on expression. These data provide further evidence on the plausible molecular mechanism underlying the aetiology of the disorder. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579365     DOI: 10.1002/ajmg.b.30572

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  40 in total

1.  Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks.

Authors:  Ariel Beth Brown; Joseph Biederman; Eve Valera; Nikos Makris; Alysa Doyle; Susan Whitfield-Gabrieli; Eric Mick; Thomas Spencer; Stephen Faraone; Larry Seidman
Journal:  Psychiatry Res       Date:  2011-05-18       Impact factor: 3.222

Review 2.  Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

Authors:  Nada A Elsayed; Kaila M Yamamoto; Tanya E Froehlich
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

3.  COMT and DAT1 genes are associated with hyperactivity and inattention traits in the 1993 Pelotas Birth Cohort: evidence of sex-specific combined effect.

Authors:  Glaucia C Akutagava-Martins; Angelica Salatino-Oliveira; Christian Kieling; Julia P Genro; Guilherme V Polanczyk; Luciana Anselmi; Ana M B Menezes; Helen Gonçalves; Fernando C Wehrmeister; Fernando C Barros; Sidia M Callegari-Jacques; Luis A Rohde; Mara H Hutz
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

4.  Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.

Authors:  Alex J Brewer; David A Nielsen; Catherine J Spellicy; Sara C Hamon; Justin Gingrich; Daisy G Y Thompson-Lake; Ellen M Nielsen; James J Mahoney; Thomas R Kosten; Thomas F Newton; Richard De La Garza
Journal:  Pharmacogenet Genomics       Date:  2015-06       Impact factor: 2.089

5.  Dopamine transporter genotype predicts implicit sequence learning.

Authors:  Jessica R Simon; Melanie Stollstorff; Lauren C Westbay; Chandan J Vaidya; James H Howard; Darlene V Howard
Journal:  Behav Brain Res       Date:  2010-09-08       Impact factor: 3.332

6.  Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms.

Authors:  Benjamin B Lahey; Paul J Rathouz; Steve S Lee; Andrea Chronis-Tuscano; William E Pelham; Irwin D Waldman; Edwin H Cook
Journal:  J Abnorm Psychol       Date:  2011-02

7.  Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Authors:  Anne-Claude Bédard; Kurt P Schulz; Edwin H Cook; Jin Fan; Suzanne M Clerkin; Iliyan Ivanov; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

8.  Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: a structural equation modeling approach.

Authors:  James J Li; Steve S Lee
Journal:  J Clin Child Adolesc Psychol       Date:  2012-11-15

9.  Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.

Authors:  Barbara Franke; Alejandro Arias Vasquez; Stefan Johansson; Martine Hoogman; Jasmin Romanos; Andrea Boreatti-Hümmer; Monika Heine; Christian P Jacob; Klaus-Peter Lesch; Miguel Casas; Marta Ribasés; Rosa Bosch; Cristina Sánchez-Mora; Núria Gómez-Barros; Noèlia Fernàndez-Castillo; Mònica Bayés; Anne Halmøy; Helene Halleland; Elisabeth T Landaas; Ole B Fasmer; Per M Knappskog; Angelien J G A M Heister; Lambertus A Kiemeney; J J Sandra Kooij; A Marije Boonstra; Cees C Kan; Philip Asherson; Stephen V Faraone; Jan K Buitelaar; Jan Haavik; Bru Cormand; Josep Antoni Ramos-Quiroga; Andreas Reif
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

10.  SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Elizabeth M Azzato; Lindsay M Morton; Andrew W Bergen; Sophia S Wang; Nilanjan Chatterjee; Paul Kvale; Meredith Yeager; Richard B Hayes; Stephen J Chanock; Neil E Caporaso
Journal:  BMC Med Genet       Date:  2009-01-30       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.